Skip to main content
European Commission logo
Live, work, travel in the EU
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

High-throughput immunoassays for SARS-CoV-2 – considerable differences in performance when comparing three methods

DOI
10.1101/2020.05.22.20106294 
Detection Principle
ImmunoAssay-Antibody
Target
IgM and IgG
Testing Method Category
Other
Testing Method
1) Abbott SARS-CoV-2 IgG on the ARCHITECT i2000 (Abbott, Illinois, USA); 2) Elecsys Anti-SARS-CoV-2 on the Cobas 8000 e801 (Roche Diagnostic Scandinavia AB, 80 Solna, Sweden); 3) LIAISON SARS-CoV-2 S1/S2 IgG on the LIAISON XL (DiaSorin, 81 Saluggia, Italy); 4) the lateral flow test 2019-nCOV IgG/IgM Rapid Test (Dynamiker 82 Biotechnology Co., Tianjin, China)
Testing Method - Additional Info
Performances opf three different comercially available high-throughput antibody assay and one rapid immunochromatographic test
Reported Performance
1) Abbott Sensitivity: 85%; Specificity: 100%; 2) Roche Sensitivity: 100%; Specificity: 98% 3) DiaSorin Sensitivity: 77.8%; Specificity: 96.9%; 4) Dynamiker Sensitivity: 75%; Specificity: 98%
Sample Size
133 patients
Peer-reviewed
no

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements